About this information
Search the summaries of completed Access to Information (ATI) requests to find information about ATI requests made to the Government of Canada after January 2020. If you find a summary of interest, you can request a copy of the records at no cost using the form below each summary. Requests made through this form are considered informal requests and are not subject to the same requirements as requests under the Access to Information Act (ATIA).
If you don’t find what you are looking for you can request additional government records under an institution’s control by contacting the institution’s Access to Information and Privacy Coordinator or by submitting a formal access to information request.
*All information provided will incorporate the necessary exemptions and exclusions as per the Access to Information Act and the Privacy Act.
Download datasets of the summaries of completed access to information requests.
Current Search
Report Type
Organization
Disposition
Year
Month
Found 4529 record(s)
Req # A-2019-000891
Original request for Natural Product Number (NPN) with product issuance letter and product licence for the following natural health product "Chest Rub Iiii; Chest Rub; Respirafect (R) Chest Rub"; NPN: 80070473; Licence holder: St. Francis…Organization: Health Canada
March 2020
Req # A-2019-001048
Complete inspection reports on Attix Corporation for the last three Health Canada inspections.Organization: Health Canada
March 2020
Req # A-2019-001390
All documentation provided by the manufacturer Cousin Biotech / Medtronics Sofamor Danek in its application for licensing with Health Canada of the following medical device: [DIAM IMPLANT-FLAT LIGAMENT] [Device class: 3] [Device Identifier: 9492212…Organization: Health Canada
March 2020
Req # A-2019-001410
A copy of the information as tracked in the Drug Submission Tracking System (“DSTS”) relating to Apotex Inc.’s drug submission for Apo-Atomoxetine.Organization: Health Canada
March 2020
Req # A-2019-001095
Adverse Reaction Report (AER). Report numbers: E2B_01310929, E2B_01310936, E2B_01310946, E2B_01914043, E2B_01310896 E2B_01914337, E2B_01310910, E2B_01310960.Organization: Health Canada
March 2020
Req # A-2019-000472
Briefing note in the Ministerial Executive Correspondence System (MECS) for the following file: 19-101214-381.Organization: Health Canada
March 2020
Req # A-2019-000530
Adverse Reaction Report (AER). Report numbers: E2B_01695269, E2B_02160801, 000714024, 000714053, E2B_02233244, E2B_01699836, E2B_01827738, E2B_02193645, 000709789, 000710048, 000718683, 000718965, 000717869, 000717876, 000718033.Organization: Health Canada
March 2020
Req # A-2019-000842
Adverse Reaction Report (AER). Report numbers: E2B_01929194, E2B_01926477, E2B_01917015, E2B_02080279, E2B_02097661, E2B_02106036, E2B_01894417, E2B_01894417, E2B_02108840 and E2B_01880486.Organization: Health Canada
March 2020
Req # A-2019-000893
Adverse Reaction Report (AER). Report numbers: E2B_02460032, E2B_02473329, E2B_02476812, E2B_02476819, E2B_02476989.Organization: Health Canada
March 2020
Req # A-2019-001121
Adverse Reaction Report (AER). Report number: E2B_02319741.Organization: Health Canada
March 2020